{"id":"W2150604072","doi":"10.1002/ajh.23728","title":"Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Pfizer; Bristol-Myers Squibb","keywords":"Bosutinib; Medicine; Internal medicine; Imatinib; Dasatinib; Nilotinib; Nausea; Adverse effect; Gastroenterology; Myeloid leukemia; Oncology; Rash; Tyrosine-kinase inhibitor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003288613,0.00048907,0.001652673,0.0006156948,0.0007705454,0.0007468231,0.0003852831,0.0006278038,0.001495103],"category_scores_gemma":[0.003075886,0.0001655741,0.001088092,0.0005253667,0.0002934601,0.0006244616,0.0003887468,0.001070435,0.0005710002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000513162,"about_ca_system_score_gemma":0.0003371352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007291632,"about_ca_topic_score_gemma":0.0008612908,"domain_scores_codex":[0.9991028,0.0002288684,0.0001140627,0.0001229789,0.0002174842,0.0002137821],"domain_scores_gemma":[0.9974994,0.0005851708,0.0008230389,0.0002117675,0.0005080916,0.0003726014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07072018,0.003201405,0.6728738,0.0004703967,0.001332175,0.002442341,0.0007723556,0.002904671,0.04311179,0.0001515977,0.003004391,0.1990149],"study_design_scores_gemma":[0.001223015,0.02637833,0.9567372,0.00003791183,0.0008791213,0.001654618,0.00008657191,0.001285554,0.008474256,0.0001085614,0.003084798,0.00005009209],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925195,0.003214944,0.0008319627,0.0001126696,0.00002516233,0.0001288054,0.0009951202,0.00005152443,0.00212028],"genre_scores_gemma":[0.997127,0.0002584136,0.0001655093,0.00008851325,0.00003075381,0.00009412136,0.001643641,0.000007267134,0.0005846919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003288613,"threshold_uncertainty_score":0.01739204,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01050857351669677,"score_gpt":0.2926125195130662,"score_spread":0.2821039459963695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}